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Angiotensin II (Ang II) acting in the brainhas been implicated in the pathogenesis
of many cardiovascular diseases, such as
arterial hypertension. One of the most impor-
tant consequences of activation of the Ang II
type 1 (AT1) receptor is enhanced nicotina-
mide adenine dinucleotide phosphate
(NADPH) oxidase activity, eliciting the pro-
duction of reactive oxygen species (ROS),
especially the superoxide anion (O2
).1–3
The close functional association between
NADPH oxidase and the renin–angiotensin
system may be of particular relevance in
linking oxidative stress to hypertension. The
brain is one of the Ang II targets most
affected by oxidative stress. In fact, the central
nervous system is involved in the develop-
ment and maintenance of Ang II-dependent
arterial hypertension.4 The rostral ventrolat-
eral medulla (RVLM) and the hypothalamic
paraventricular nucleus (PVN) are the major
regions related to sympathetic activation dur-
ing the development of arterial hyperten-
sion.4 Recently, we showed that AT1 gene
expression receptors are upregulated in the
RVLM and PVN areas of renovascular hyper-
tensive rats.5 Furthermore, expression of
NADPH oxidase subunits (p47 phox and gp
91 phox) was increased in the PVN and
RVLM areas of renovascular hypertensive
rats. Tempol administration into the PVN
or RVLM decreased blood pressure and
renal sympathetic nerve activity only in
hypertensive rats, suggesting that renal sym-
pathetic hyperactivity and hypertension are
associated with an increase in central oxida-
tive stress. One possible mechanism by which
circulating Ang II exerts its effects centrally is
by binding to its receptors on neurons in
specialized brain regions that lack a blood–
brain barrier, that is, the circumventricular
organs (CVOs). The CVOs are populated
with fenestrated capillaries for high perme-
ability and are known to be pivotal in med-
iating the increase in blood pressure in
response to circulating Ang II. Neurons in
these regions, such as the subfornical organ
and the organum vasculosum of the lamina
terminalis, can be activated by circulating
Ang II and they then signal to other down-
stream cardiovascular control regions of the
brain, such as the RVLM and the PVN, which
further activate several neurohumoral path-
ways (Figure 1). However, the exact mechan-
ism by which circulating Ang II leads to an
increase in oxidative stress in the sympathetic
premotor neurons is unclear. Paterson et al.6
showed that gp91phox is abundantly
expressed in CVOs and identified gp91phox
as having a key role in central Ang II-induced
cardiovascular responses by increasing ROS
production, suggesting a strong relationship
between upregulation of mRNA NADPH
subunits, particularly gp91phox and
p47phox, and increased oxidative stress in
the central nervous system in response to
circulating Ang II. In an interesting paper,
Chan et al.7 demonstrated that phosphoryla-
tion of p47phox serine residues induced by
Ang II in the RVLM, which was blunted by
the AT1 receptor antagonist losartan, mani-
fested a temporal profile that correlated posi-
tively with the O2 production induced by Ang
II. Therefore, these results could imply that
enhanced central Ang II action stimulates
NADPH oxidase in the central nervous sys-
tem, leading to increased O2 formation and
thereby an increase in sympathetic activity
and arterial hypertension. Furthermore, Kishi
et al.8 showed that thiobarbituric acid-reac-
tive substance levels were increased in the
RVLM of spontaneously hypertensive rats
(SHRs) compared with Wistar–Kyoto rats.
Tempol injected into this region decreased
blood pressure in a dose-dependent manner
in the hypertensive group but not in the
control group, suggesting that in this model
central oxidative stress is a major mechanism
for maintained hypertension. Therefore, it is
plausible that chronic Ang II AT1 receptor
antagonist treatment in hypertension decreases
central oxidative stress and blood pressure.
Interestingly, the paper from Araki et al.9
showed that chronic olmesartan treatment
in stroke-prone SHR (SHRSP) rats decreased
oxidative stress in the brain and norepineph-
rine excretion. More importantly, they showed
that the same reduction in blood pressure
afforded by hydralazine/hydrochlorothiazide
(Hyd/HCT) did not reduce brain oxidative
stress, suggesting that a specific antioxidant
effect in the brain was mediated by the AT1
receptor antagonist; this effect seemed to be
independent of the reduction in blood pres-
sure. Finally, they showed that the decrease
in blood pressure in response to olmesartan,
unlike Hyd/HCT, did not induce a baroreflex-
mediated increase in HR and sympathetic
activity despite similar reductions in blood
pressure, indicating that olmesartan has an
anti-oxidative role in the brain without stimu-
lating reflex-mediated sympathetic activity in
the SHRSP. These experiments shed new light
on the importance of the central effects of
Ang II and oxidative stress in the brain in
arterial hypertension and sympathoexcitation.
However, the source of superoxide formation
in regions of the brain involved in cardio-
vascular control has not been determined;
whether AT1 receptor activation can specifi-
cally increase ROS formation in cardiovascular
or non-cardiovascular neurons or in glial cells
or in endothelial cells remains to be estab-
lished. Thus, longer-term activation of the
AT1 receptor in the brain may have the
potential for deleterious positive-feedback
effects of Ang II’s actions on the central
nervous system, and this may play a major
role in hypertension. Elucidating the mechan-
ism involved in the central sympathoexcitation
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mediated by Ang II and oxidative stress may
result in a new paradigm for treating arterial
hypertension. However, further integrative
and molecular studies are necessary for a
better understanding of the balance between
peripheral and central oxidative stress and its
contribution to arterial hypertension.
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Figure 1 Schematic representation of the possible central pathways involved in the sympathetic activation induced by increases in central oxidative stress in
response to an increase in circulating angiotensin II.
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